GE HealthCare Leads Thera4Care Initiative to Broaden Theranostics Access Across Europe
Slice of Healthcare Team
Oct 10, 2024
Key Highlights
- GE HealthCare leads €25.3M Thera4Care project to expand theranostics access in Europe.
- Theranostics integrates imaging diagnostics and targeted therapy for precision cancer treatment.
- 29 partners from academic, clinical, and patient advocacy groups join the effort.
- Focus areas include prostate, ovarian, pancreatic cancers, and sarcomas.
- AI-enabled imaging and predictive analytics will enhance patient outcomes.
Source: Business Wire
Notable Quote
“ Our collective efforts are designed to improve healthcare system readiness for this rapidly growing field of precision medicine. ”
Dr. Ben Newton, General Manager, Oncology Solutions at GE HealthCare
